688298 東方生物
按盤價 
24.130 -0.140 (-0.577%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.270 | -7.514 | -5.098 | 27.533 | 105.774 |
| 總資產報酬率 ROA (%) | -2.726 | -6.191 | -4.036 | 21.013 | 78.408 |
| 投入資產回報率 ROIC (%) | -3.058 | -6.908 | -4.613 | 25.748 | 101.227 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.637 | 31.741 | 43.011 | 50.793 | 73.790 |
| 營業利潤率 (%) | -34.863 | -69.914 | -46.800 | 28.835 | 56.803 |
| 息稅前利潤/營業總收入 (%) | -45.751 | -96.948 | -82.888 | 21.299 | 57.401 |
| 淨利潤/營業總收入 (%) | -34.411 | -68.705 | -50.999 | 23.922 | 48.585 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.654 | 72.198 | 45.059 | 149.748 | 100.555 |
| 價值變動淨收益/利潤總額(%) | -4.477 | -6.908 | -8.170 | 0.311 | 0.194 |
| 營業外收支淨額/利潤總額(%) | 0.216 | 1.107 | 5.045 | -2.326 | -0.111 | 償債能力分析 |
| 流動比率 (X) | 4.279 | 3.305 | 5.430 | 3.839 | 3.948 |
| 速動比率 (X) | 3.857 | 3.049 | 5.111 | 3.650 | 3.719 |
| 資產負債率 (%) | 13.518 | 16.099 | 16.076 | 22.242 | 23.262 |
| 帶息債務/全部投入資本 (%) | 4.287 | 6.197 | 7.752 | 9.840 | 0.899 |
| 股東權益/帶息債務 (%) | 2,208.420 | 1,491.271 | 1,180.349 | 910.406 | 10,972.267 |
| 股東權益/負債合計 (%) | 626.724 | 509.926 | 514.172 | 342.869 | 328.380 |
| 利息保障倍數 (X) | 4.231 | 3.693 | 2.467 | -3.096 | 86.813 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 91.190 | 94.411 | 113.141 | 30.666 | 32.042 |
| 存貨周轉天數 (天) | 220.708 | 208.859 | 299.881 | 37.652 | 57.548 |
| 備註： | 即時報價更新時間為 26/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
